Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
New Research From Rabin Medical Center May Lead to Cure for Melanoma
A group of researchers from Tel Aviv University has discovered how malignant tumors from melanoma, the deadly skin cancer, work. The group is led by a young lecturer and researcher, Dr. Carmit Levy.
A Leader in Global Oncology: Rabin Medical Center’s Davidoff Cancer Center
Davidoff Cancer Center is an international leader in cancer care and has set the standard as Israel’s first and preeminent comprehensive cancer center.
New Generation of Artificial Heart, Implanted for the First Time at Israel’s Rabin Medical Center
A new type of artificial heart – the Heart Mate 3, which gives the recipient a pulse and blood pressure – has been imported and implanted here for the first time at the Rabin Medical Center- Beilinson in Petah Tikva.